Magazine

Most Recent

image: Christina Schmidt: Chronobiology Crusader

Christina Schmidt: Chronobiology Crusader

By | March 1, 2016

Research Fellow, Cyclotron Research Center, University of Liège. Age: 35

0 Comments

image: Contributors

Contributors

By | March 1, 2016

Meet some of the people featured in the March 2016 issue of The Scientist.

0 Comments

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

image: Dial It Up, Dial It Down

Dial It Up, Dial It Down

By | March 1, 2016

Newer CRISPR tools for manipulating transcription will help unlock noncoding RNA’s many roles.

0 Comments

image: Getting Animal Research Right

Getting Animal Research Right

By | March 1, 2016

Regulatory and compliance expectations for animal-based research are demanding, while public and political scrutiny of animal research is rising.

2 Comments

image: In Dogged Pursuit of Sleep

In Dogged Pursuit of Sleep

By | March 1, 2016

Unearthing the root causes of narcolepsy keeps Emmanuel Mignot tackling one of sleep science’s toughest questions.

0 Comments

image: In Your Dreams

In Your Dreams

By | March 1, 2016

Understanding the sleeping brain may be the key to unlocking the secrets of the human mind.

1 Comment

image: Learning with the Lights Out

Learning with the Lights Out

By | March 1, 2016

Researchers are uncovering the link between sleep and learning and how it changes throughout our lives.

1 Comment

image: Out in the Cold

Out in the Cold

By | March 1, 2016

Serotonin’s long-debated role in sleep promotion is temperature-dependent.

1 Comment

image: Perchance to Dream

Perchance to Dream

By | March 1, 2016

Mapping the dreaming brain through neuroimaging and studies of brain damage

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech